Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹3.5 CrAccepted-AOC | ₹3.5 Cr Quoted ₹2.3 Cr | L1 | Accepted-AOC Item wise lowest selection |
| 2 | L2₹4.1 Cr+₹3.7 Cr (161.2%)Accepted-AOC 709 CADILA CORPORATE CAMPUS SARKHEJ DHOLKA ROAD BHAT AHMEDABAD GUJARAT 382210 | AHMADABAD | GUJARAT | 382210 | ₹4.1 Cr+₹3.7 Cr (161.2%) Quoted ₹5.9 Cr | L2 | Accepted-AOC Item wise lowest selection |
| 3 | L3₹8.1 Cr+₹5.8 Cr (256.4%)Rejected-Finance 5TH FLOOR ANUVRAT BHAWAN 210 DEEN DAYAL UPADHYAYA MARG NEW DELHI CENTRAL DELHI DELHI 110002 | CENTRAL DELHI | DELHI | 110002 | ₹8.1 Cr+₹5.8 Cr (256.4%) | L3 | Rejected-Finance L3, as per total bidding amount |
| 4 | L4₹23.3 Cr+₹21.1 Cr (928.1%)Rejected-Finance | ₹23.3 Cr+₹21.1 Cr (928.1%) | L4 | Rejected-Finance L4, as per total bidding price |
| 5 | L5₹56.0 Cr+₹53.7 Cr (2365.9%)Rejected-Finance | ₹56.0 Cr+₹53.7 Cr (2365.9%) | L5 | Rejected-Finance L5. as per total bidding amount |
Tender Value
Refer Docs
EMD Value
₹15 L
Closing Date
10 Jun 2020, 11:00 amClosed
Director CSIR IIIM CANAL ROAD JAMMU
CSIR IIIM CANAL ROAD JAMMU
Outsourcing clinical trials related to COVID-19
2020_CSIR_49102_1
12(288)/2020-P
Open Tender
Miscellaneous Services
Supply
120 days
CSIR IIIM CANAL ROAD JAMMU
Please refer Tender documents.
5 documents required · 5 mandatory
₹0
₹15 L
Yes
Online mode
15 Jun 2020
27 May 2020
11 Jun 2020
27 May 2020
10 Jun 2020
27 May 2020
29 May 2020
Study 1 Ayurvedic formulation-1 for the Prophylaxis against SARS-CoV-2 Infection: A Randomized Hydroxychloroquine Controlled Clinical Trial in Health Care Providers
Charges for ethics committee approval and agreement (between CRO, Sponsor, sites)
Charges for CTRI registration
Charges for data collection and data management from site/hospital, data cleaning/biostatistics, preparation of final report and submission to sponsor.
Charges for indemnifying CSIR-IIIM/CCRAS for any harm liability and causality
Basic site cost (screening, consent, clinical exam, life questionnaire, follow up assessments, investigators, paramedics, pharmacy, participant comfort, SOC, etc) on per patient basis
Rates for Laboratory Investigations as per specifications in NIT, on per patient basis
Charges for clinical trial liability insurance on per patient basis
Charges for compilation of entire clinical trials data and submission of the dossier to DCGI and attending to queries post submission of the dossier.
Charges for compilation of publication/s (Manuscript preparation, submission and resolution of query) – One publication per study.
Total Study -1
STUDY 2 : A Randomized, Open Label, Parallel Efficacy, Active Control, Multi-Centre Exploratory Drug Trial to Evaluate Efficacy and Safety of an Ayurvedic Formulation-2 as Adjunct Treatment to Standard of Care for the management of Mild to Moderate COVID-19 Patients
Charges for ethics committee approval and agreement (between CRO, Sponsor, sites)
Charges for CTRI registration
Charges for data collection and data management from site/hospital, data cleaning/biostatistics, preparation of final report and submission to sponsor.
Charges for indemnifying CSIR-IIIM/CCRAS for any harm liability and causality
Basic site cost (screening, consent, clinical exam, life questionnaire, follow up assessments, investigators, paramedics, pharmacy, participant comfort, SOC, etc) on per patient basis
Rates for Laboratory Investigations as per specifications in NIT, on per patient basis
Charges for clinical trial liability insurance on per patient basis
Charges for compilation of entire clinical trials data and submission of the dossier to DCGI and attending to queries post submission of the dossier.
Charges for compilation of publication/s (Manuscript preparation, submission and resolution of query) – One publication per study.
Total Study -2
Study 3: A Randomized, Open Label, Parallel Efficacy, Active Control, Multi-Centre Exploratory Drug Trial to Evaluate Efficacy and Safety of an Ayurvedic Formulation-3 as Adjunct Treatment to Standard of Care for the management of Mild to Moderate COVID-19 Patients
Charges for ethics committee approval and agreement (between CRO, Sponsor, sites)
Charges for CTRI registration
Charges for data collection and data management from site/hospital, data cleaning/biostatistics, preparation of final report and submission to sponsor.
Charges for indemnifying CSIR-IIIM/CCRAS for any harm liability and causality
Basic site cost (screening, consent, clinical exam, life questionnaire, follow up assessments, investigators, paramedics, pharmacy, participant comfort, SOC, etc) on per patient basis
Rates for Laboratory Investigations as per specifications in NIT, on per patient basis
Charges for clinical trial liability insurance on per patient basis
Charges for compilation of entire clinical trials data and submission of the dossier to DCGI and attending to queries post submission of the dossier.
Charges for compilation of publication/s (Manuscript preparation, submission and resolution of query) – One publication per study.
Total Study - 3
Study 4: A Randomized, Open Label, Parallel Efficacy, Active Control, Multi-Centre Exploratory Drug Trial to Evaluate Efficacy and Safety of an Ayurvedic Formulation-4 as Adjunct Treatment to Standard of Care for the management of Mild to Moderate COVID-19 Patients
Charges for ethics committee approval and agreement (between CRO, Sponsor, sites)
Charges for CTRI registration
Charges for data collection and data management from site/hospital, data cleaning/biostatistics, preparation of final report and submission to sponsor.
Charges for indemnifying CSIR-IIIM/CCRAS for any harm liability and causality
Basic site cost (screening, consent, clinical exam, life questionnaire, follow up assessments, investigators, paramedics, pharmacy, participant comfort, SOC, etc) on per patient basis
Rates for Laboratory Investigations as per specifications in NIT, on per patient basis
Charges for clinical trial liability insurance on per patient basis
Charges for compilation of entire clinical trials data and submission of the dossier to DCGI and attending to queries post submission of the dossier.
Charges for compilation of publication/s (Manuscript preparation, submission and resolution of query) – One publication per study.
Total Study -4
Cadila Pharmaceuticals Limited
BIOTECH CONSORTIUM INDIA LIMITED
Ethicare
AILEEN Clinical Research Services
stage.html
html • 0.06 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
aoc.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .